Your browser doesn't support javascript.
loading
hPG80 (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors.
Chauhan, Aman; Prieur, Alexandre; Kolesar, Jill; Arnold, Susanne; Payen, Léa; Mahi, Younes; Vire, Berengere; Sands, Madison; Evers, B Mark; Joubert, Dominique; Anthony, Lowell.
Afiliação
  • Chauhan A; Division of Medical Oncology, and the Markey Cancer Center, University of Kentucky, Lexington, KY 40536, USA.
  • Prieur A; ECS Progastrin, 1004 Lausanne, Switzerland.
  • Kolesar J; College of Pharmacy, and the Markey Cancer Center, University of Kentucky, Lexington, KY 40536, USA.
  • Arnold S; Division of Medical Oncology, and the Markey Cancer Center, University of Kentucky, Lexington, KY 40536, USA.
  • Payen L; Lyon Sud Hospital, 69310 Pierre-Benite, France.
  • Mahi Y; ECS Progastrin, 1004 Lausanne, Switzerland.
  • Vire B; ECS Progastrin, 1004 Lausanne, Switzerland.
  • Sands M; School of Medicine, University of Kentucky, Lexington, KY 40536, USA.
  • Evers BM; Department of Surgery, and the Markey Cancer Center, University of Kentucky, Lexington, KY 40536, USA.
  • Joubert D; ECS Progastrin, 1004 Lausanne, Switzerland.
  • Anthony L; Division of Medical Oncology, and the Markey Cancer Center, University of Kentucky, Lexington, KY 40536, USA.
Cancers (Basel) ; 14(4)2022 Feb 09.
Article em En | MEDLINE | ID: mdl-35205614
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article